Voyageur Pharmaceuticals Statistics

Total Valuation

Voyageur Pharmaceuticals has a market cap or net worth of 8.72 million. The enterprise value is 8.75 million.

Market Cap	8.72M
Enterprise Value	8.75M

Important Dates

The next estimated earnings date is Monday, March 24, 2025.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+8.55%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	125.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	12.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.71
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.54

Financial Position

The company has a current ratio of 0.10, with a Debt / Equity ratio of 0.04.

Current Ratio	0.10
Quick Ratio	0.03
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -115.50% and return on invested capital (ROIC) is -61.53%.

Return on Equity (ROE)	-115.50%
Return on Assets (ROA)	-37.08%
Return on Capital (ROIC)	-61.53%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.71% in the last 52 weeks. The beta is 0.32, so Voyageur Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+107.71%
50-Day Moving Average	0.04
200-Day Moving Average	0.05
Relative Strength Index (RSI)	81.92
Average Volume (20 Days)	441

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-991,039
Pretax Income	-1.13M
Net Income	-1.13M
EBITDA	-989,761
EBIT	-991,039
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 4,843 in cash and 29,641 in debt, giving a net cash position of -24,799.

Cash & Cash Equivalents	4,843
Total Debt	29,641
Net Cash	-24,799
Net Cash Per Share	n/a
Equity (Book Value)	700,145
Book Value Per Share	0.01
Working Capital	-893,446

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -250,115 and capital expenditures -121,412, giving a free cash flow of -371,527.

Operating Cash Flow	-250,115
Capital Expenditures	-121,412
Free Cash Flow	-371,527
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Voyageur Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.55%
Shareholder Yield	-8.55%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a